Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MatchTx
AddedFeb 19, 2024
UpdatedJun 18, 2026
MatchTx

MatchTx

Seed

MatchTx: Leveraging big data for predictive genome analytics to match patients with optimal cancer treatments.

HQ
Columbus, OH, US
Founded
2015
Overview
Compare
Fundraising
Employees

MatchTx is a big data healthcare analytics software company focused on predictive genome analytics. Their core mission is to match patients with the most effective cancer treatments and clinical trials using genetic, clinical, and outcome data. The technology, exclusively licensed from The Ohio State University, aims to revolutionize personalized cancer care.

MatchTx has achieved significant milestones, including securing a $125,000 grant from the Third Frontier Program of the State of Ohio. Initial equity investments have facilitated the development of their commercial product, positioning the company as a leader in personalized cancer treatment solutions.

MatchTx - Similar Companies

MolecularMatch logo

MolecularMatch

molecularmatch.com

PanGenX logo

PanGenX

BostonGene logo

BostonGene

bostongene.com

GenomOncology logo

GenomOncology

genomoncology.com

Station X logo

Station X

MyCancerDB logo

MyCancerDB

ennov1.com

Genomenon logo

Genomenon

genomenon.com

Empiri logo

Empiri

empiricancer.com

Trial Library logo

Trial Library

triallibrary.com

Triomics logo

Triomics

triomics.com

Oncobox logo

Oncobox

oncobox.com

GeneCentrix logo

GeneCentrix

genecentrix.com

GenomeNext logo

GenomeNext

Isabl logo

Isabl

isabl.io

DNA SEQ logo

DNA SEQ

MatchTx - Quick Facts

Who are MatchTx's competitors?

Companies similar to MatchTx include MolecularMatch, PanGenX, BostonGene and GenomOncology.

When was MatchTx founded?

MatchTx was founded in 2015.

Where is MatchTx's headquarters located?

MatchTx's headquarters is located in Columbus, OH, US.

When was MatchTx's last funding round?

MatchTx's most recent funding round was for $250k (USD) in July 2022.

How much has MatchTx raised to-date?

As of Jul 29, 2022, MatchTx has raised a total of $350k (USD).

How many employees does MatchTx have?

MatchTx has 6 employees as of Feb 5, 2024.

MatchTx - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Analytics Software
Tags
  • Biotech
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services